Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

BenevolentAI

Explore full profile

BenevolentAI is a leading, clinical-stage AI-enabled drug discovery company

London, United KingdomFounded 2013Biotech & Life Sciences
Revenue $6.9M Latest reported FY

At a glance

Status
Listed
Founded
2013
Headquarters
London, United Kingdom
Listing
Public via SPAC 2021
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tier

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later6 investors entered at this stage

Employees mapped 69 incl. 18 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 15 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 10 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇬🇧 United Kingdom94.3%
🇺🇸 United States5.4%
🇮🇹 Italy1%
🇫🇷 France0.7%
4 countries shown
Web traffic by country
14K monthly visits
across markets
🇮🇳 India36.4%
🇺🇸 United States27.9%
🇬🇧 United Kingdom21.4%
🇨🇦 Canada5.7%
🇫🇷 France2.1%
Top 5 markets shown

Patents

Estimated portfolio value
$3M

29 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about BenevolentAI on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See BenevolentAI on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.